Market Overview

TCR2 Therapeutics Inc. (TCRR)

18.53 +0.48 (2.66%)

Analyst Ratings

DateResearch FirmActionCurrentPT
8/21/20MizuhoInitiates Coverage OnBuy
8/13/20Truist SecuritiesInitiates Coverage OnBuy40.0
8/13/20HC Wainwright & Co.MaintainsBuy32.0
8/12/20SVB LeerinkMaintainsOutperform25.0
8/12/20Piper SandlerInitiates Coverage OnOverweight35.0
7/27/20Roth CapitalUpgradesBuy35.0
7/27/20HC Wainwright & Co.MaintainsBuy33.0
11/04/19HC Wainwright & Co.Initiates Coverage OnBuy19.0
5/31/19Roth CapitalInitiates Coverage OnNeutral16.0
3/11/19WedbushInitiates Coverage OnOutperform28.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter